Trial intelligence / Profile preview

Oral Dissolution Therapy for Radiolucent Renal Stones

NCT02373384Phase 4Completed

Sponsor
Mansoura University
Start
Feb 2015
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of potassium citrate in nephrolithiasis, sponsored by Mansoura University. Primary endpoint: Change in stone surface area at 12 weeks. Started Feb 2015; status: completed.

02

Drugs

potassium citrate
03

Conditions

nephrolithiasis

Beyond the preview

Go deeper on NCT02373384.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02373384.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call